Starting from the concept that immunotherapy is certainly one of the last frontiers in the treatment of cancer, in the work of Daga et al. [114], a mouse orthotopic model of glioma was studied using either genetically modified IL-21 or recombinant IL-21 cells as the treatment. This evidence concerns the gene IL21 and cancer.